| Drug Name | Recormon (NeoRecormon) |
|---|---|
| Drug Class |
Hematopoietic growth factor
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Hematology
|
| Risk |
New warning on sever cutaneous adverse reactions |
| Dear Healthcare provider letter DHPC |
|